According to SNS Insider, global Bioconjugation Market growth is driven by active biopharmaceutical R&D, improvements in conjugation chemistries, and the increasing use of antibody-drug ...
In 2024, North America held a dominan market position, capturing more than a 42.6% share, holding USD 227.61 Billion revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback